ID: MRFR/HC/6046-HCR | 85 Pages | Author: Rahul Gotadki | November 2023
Table of Contents:
Chapter 1. Report Prologue
Chapter 2. Market Introduction
2.1. Definition
2.2. Scope of the Study
2.2.1. Research Objective
2.2.2. Assumptions
2.2.3. Limitations
Chapter 3. Research Methodology
3.1. Introduction
3.2. Primary Research
3.3. Secondary Research
3.4. Market Size Estimation
Chapter 4. Market Dynamics
4.1. Drivers
4.2. Restraints
4.3. Opportunities
4.4. Challenges
4.5. Macroeconomic Indicators
Chapter 5. Market Factor Analysis
5.1. Porter’s Five Forces Analysis
5.1.1. Bargaining Power of Suppliers
5.1.2. Bargaining Power of Buyers
5.1.3. Threat of New Entrants
5.1.4. Threat of Substitutes
5.1.5. Intensity of Rivalry
5.2. Value Chain Analysis
5.3. Investment Feasibility Analysis
5.4. Pricing Analysis
Chapter 6. Global Poultry Vaccines Market, by Diseases
6.1. Introduction
6.2. Infectious bronchitis
Market Estimates & Forecast, by Region, 2023-2032
Market Estimates & Forecast, by Country, 2023-2032
6.3. Avian Influenza
Market Estimates & Forecast, by Region, 2023-2032
Market Estimates & Forecast, by Country, 2023-2032
6.4. Marek's Disease
Market Estimates & Forecast, by Region, 2023-2032
Market Estimates & Forecast, by Country, 2023-2032
6.5. Newcastle Disease
Market Estimates & Forecast, by Region, 2023-2032
Market Estimates & Forecast, by Country, 2023-2032
6.6. Others
Chapter 7. Global Poultry Vaccines Market, by Technology
7.1. Introduction
7.2. Toxoid Vaccines
Market Estimates & Forecast, by Region, 2023-2032
Market Estimates & Forecast, by Country, 2023-2032
7.3. Recombinant Vaccines
Market Estimates & Forecast, by Region, 2023-2032
Market Estimates & Forecast, by Country, 2023-2032
7.4. Inactivated Vaccines
Market Estimates & Forecast, by Region, 2023-2032
Market Estimates & Forecast, by Country, 2023-2032
7.5. Live Attenuated Vaccines (LAV)
Market Estimates & Forecast, by Region, 2023-2032
Market Estimates & Forecast, by Country, 2023-2032
7.6. Others
Chapter 8. Global Poultry Vaccines Market, by Dosage Form
8.1. Introduction
8.2. Duct Vaccines
Market Estimates & Forecast, by Region, 2023-2032
Market Estimates & Forecast, by Country, 2023-2032
8.3. Liquid Vaccines
Market Estimates & Forecast, by Region, 2023-2032
Market Estimates & Forecast, by Country, 2023-2032
8.4. Freeze Dried Vaccines
Market Estimates & Forecast, by Region, 2023-2032
Market Estimates & Forecast, by Country, 2023-2032
8.5. Others
Chapter 9. Global Poultry Vaccines Market, by Region
9.1. Introduction
9.2. Americas
9.2.1. North America
9.2.1.1. US
9.2.1.2. Canada
9.2.2. Latin America
9.3. Europe
9.3.1. Western Europe
9.3.1.1. Germany
9.3.1.2. France
9.3.1.3. Italy
9.3.1.4. Spain
9.3.1.5. UK
9.3.1.6. Rest of Western Europe
9.3.2. Eastern Europe
9.4. Asia-Pacific
9.4.1. Japan
9.4.2. China
9.4.3. India
9.4.4. Australia
9.4.5. South Korea
9.4.6. Rest of Asia-Pacific
9.5. Middle East & Africa
9.5.1. Middle East
9.5.2. Africa
Chapter 10. Company Landscape
10.1. Introduction
10.2. Market Share Analysis
10.3. Key Developments & Strategies
Chapter 11. Company Profiles
11.1. Boehringer Ingelheim GmbH
11.1.1. Company Overview
11.1.2. Product Overview
11.1.3. Financials Overview
11.1.4. Key Developments
11.1.5. SWOT Analysis
11.1.6. Key Strategies
11.2. Elanco
11.2.1. Company Overview
11.2.2. Product Overview
11.2.3. Financials Overview
11.2.4. Key Developments
11.2.5. SWOT Analysis
11.2.6. Key Strategies
11.3. MSD & Co.
11.3.1. Company Overview
11.3.2. Product Overview
11.3.3. Financials Overview
11.3.4. Key Developments
11.3.5. SWOT Analysis
11.3.6. Key Strategies
11.4. Zoetis Inc
11.4.1. Company Overview
11.4.2. Product Overview
11.4.3. Financials Overview
11.4.4. Key Developments
11.4.5. SWOT Analysis
11.4.6. Key Strategies
11.5. Ceva Animal Health Inc.
11.5.1. Company Overview
11.5.2. Product Overview
11.5.3. Financials Overview
11.5.4. Key Developments
11.5.5. SWOT Analysis
11.5.6. Key Strategies
11.6. Phibro Animal Health Corporation
11.6.1. Company Overview
11.6.2. Product Overview
11.6.3. Financials Overview
11.6.4. Key Developments
11.6.5. SWOT Analysis
11.6.6. Key Strategies
11.7. Virbac
11.7.1. Company Overview
11.7.2. Product Overview
11.7.3. Financials Overview
11.7.4. Key Developments
11.7.5. SWOT Analysis
11.7.6. Key Strategies
11.8. Hipra
11.8.1. Company Overview
11.8.2. Product Overview
11.8.3. Financials Overview
11.8.4. Key Developments
11.8.5. SWOT Analysis
11.8.6. Key Strategies
11.9. Venkys
11.9.1. Company Overview
11.9.2. Product Overview
11.9.3. Financials Overview
11.9.4. Key Developments
11.9.5. SWOT Analysis
11.9.6. Key Strategies
11.10. Biovet
11.10.1. Company Overview
11.10.2. Product Overview
11.10.3. Financials Overview
11.10.4. Key Developments
11.10.5. SWOT Analysis
11.10.6. Key Strategies
11.11. Anicon GmbH
11.11.1. Company Overview
11.11.2. Product Overview
11.11.3. Financials Overview
11.11.4. Key Developments
11.11.5. SWOT Analysis
11.11.6. Key Strategies
11.12. Others
Chapter 12. MRFR Conclusion
12.1. Key Findings
12.1.1. From CEO’s View point
12.1.2. Unmet Needs of the Market
12.2. Key Companies to Watch
12.3. Predictions for the Poultry Vaccines Industry
Chapter 13. Appendix
LIST OF TABLES
Table 1. Global Poultry Vaccines Market Synopsis, 2023-2032
Table 2. Global Poultry Vaccines Market Estimates and Forecast, 2023-2032 (USD Million)
Table 3. Global Poultry Vaccines Market, by Region, 2023-2032 (USD Million)
Table 4. Global Poultry Vaccines Market, by Diseases, 2023-2032 (USD Million)
Table 5. Global Poultry Vaccines Market, by Technology, 2023-2032 (USD Million)
Table 6. Global Poultry Vaccines Market, by Dosage Form, 2023-2032 (USD Million)
Table 7. North America: Poultry Vaccines Market, by Diseases, 2023-2032 (USD Million)
Table 8. North America: Poultry Vaccines Market, by Technology, 2023-2032 (USD Million)
Table 9. North America: Poultry Vaccines Market, by Dosage Form, 2023-2032 (USD Million)
Table 10. US: Poultry Vaccines Market, by Diseases, 2023-2032 (USD Million)
Table 11. US: Poultry Vaccines Market, by Technology, 2023-2032 (USD Million)
Table 12. US: Poultry Vaccines Market, by Dosage Form, 2023-2032 (USD Million)
Table 13. Canada: Poultry Vaccines Market, by Diseases, 2023-2032 (USD Million)
Table 14. Canada: Poultry Vaccines Market, by Technology, 2023-2032 (USD Million)
Table 15. Canada: Poultry Vaccines Market, by Dosage Form, 2023-2032 (USD Million)
Table 16. Latin America: Poultry Vaccines Market, by Diseases, 2023-2032 (USD Million)
Table 17. Latin America: Poultry Vaccines Market, by Technology, 2023-2032 (USD Million)
Table 18. Latin America: Poultry Vaccines Market, by Dosage Form, 2023-2032 (USD Million)
Table 19. Europe: Poultry Vaccines Market, by Diseases, 2023-2032 (USD Million)
Table 20. Europe: Poultry Vaccines Market, by Technology, 2023-2032 (USD Million)
Table 21. Europe: Poultry Vaccines Market, by Dosage Form, 2023-2032 (USD Million)
Table 22. Western Europe: Poultry Vaccines Market, by Diseases, 2023-2032 (USD Million)
Table 23. Western Europe: Poultry Vaccines Market, by Technology, 2023-2032 (USD Million)
Table 24. Western Europe: Poultry Vaccines Market, by Dosage Form, 2023-2032 (USD Million)
Table 25. Eastern Europe: Poultry Vaccines Market, by Diseases, 2023-2032 (USD Million)
Table 26. Eastern Europe: Poultry Vaccines Market, by Technology, 2023-2032 (USD Million)
Table 27. Eastern Europe: Poultry Vaccines Market, by Dosage Form, 2023-2032 (USD Million)
Table 28. Asia-Pacific: Poultry Vaccines Market, by Diseases, 2023-2032 (USD Million)
Table 29. Asia-Pacific: Poultry Vaccines Market, by Technology, 2023-2032 (USD Million)
Table 30. Asia-Pacific: Poultry Vaccines Market, by Dosage Form, 2023-2032 (USD Million)
Table 31. Middle East & Africa: Poultry Vaccines Market, by Diseases, 2023-2032 (USD Million)
Table 32. Middle East & Africa: Poultry Vaccines Market, by Technology, 2023-2032 (USD Million)
Table 33. Middle East & Africa: Poultry Vaccines Market, by Dosage Form, 2023-2032 (USD Million)
LIST OF FIGURES
Figure 1. Research Process
Figure 2. Segmentation for Global Poultry Vaccines Market
Figure 3. Segmentation Market Dynamics for Global Poultry Vaccines Market
Figure 4. Global Poultry Vaccines Market Share, by Diseases, 2020
Figure 5. Global Poultry Vaccines Market Share, by Technology, 2020
Figure 6. Global Poultry Vaccines Market Share, by Dosage Form, 2020
Figure 7. Global Poultry Vaccines Market Share, by Region, 2020
Figure 8. North America: Poultry Vaccines Market Share, by Country, 2020
Figure 9. Europe: Poultry Vaccines Market Share, by Country, 2020
Figure 10. Asia-Pacific: Poultry Vaccines Market Share, by Country, 2020
Figure 11. Middle East & Africa: Poultry Vaccines Market Share, by Country, 2020
Figure 12. Global Poultry Vaccines Market: Company Share Analysis, 2020 (%)
Figure 13. Boehringer Ingelheim GmbH: Key Financials
Figure 14. Boehringer Ingelheim GmbH: Segmental Revenue
Figure 15. Boehringer Ingelheim GmbH: Geographical Revenue
Figure 16. Elanco: Key Financials
Figure 17. Elanco: Segmental Revenue
Figure 18. Elanco: Geographical Revenue
Figure 19. MSD & Co.: Key Financials
Figure 20. MSD & Co.: Segmental Revenue
Figure 21. MSD & Co.: Geographical Revenue
Figure 22. Zoetis: Key Financials
Figure 23. Zoetis: Segmental Revenue
Figure 24. Zoetis: Geographical Revenue
Figure 25. Ceva Animal Health Inc.: Key Financials
Figure 26. Ceva Animal Health Inc.: Segmental Revenue
Figure 27. Ceva Animal Health Inc.: Geographical Revenue
Figure 28. Phibro Animal Health Corporation: Key Financials
Figure 29. Phibro Animal Health Corporation: Segmental Revenue
Figure 30. Phibro Animal Health Corporation: Geographical Revenue
Figure 31. Virbac: Key Financials
Figure 32. Virbac: Segmental Revenue
Figure 33. Virbac: Geographical Revenue
Figure 34. Hipra: Key Financials
Figure 35. Hipra: Segmental Revenue
Figure 36. Hipra: Geographical Revenue
Figure 37. Venkys: Key Financials
Figure 38. Venkys: Segmental Revenue
Figure 39. Venkys: Geographical Revenue
Figure 40. Biovet: Key Financials
Figure 41. Biovet: Segmental Revenue
Figure 42. Biovet: Geographical Revenue
Figure 43. Anicon GmbH: Key Financials
Figure 44. Anicon GmbH: Segmental Revenue
Figure 45. Anicon GmbH: Geographical Revenue
Poultry Vaccines Market Segmentation
Poultry Vaccines Diseases Outlook (USD Billion, 2018-2032)
Infectious Bronchitis
Marek’s Disease
Poultry Vaccines Technology Outlook (USD Billion, 2018-2032)
Toxoid
Recombinant
Inactivated
Live Attenuated Vaccines
Poultry Vaccines Dosage Form Outlook (USD Billion, 2018-2032)
Duct
Liquid
Freeze Dried Vaccines
Poultry Vaccines Regional Outlook (USD Billion, 2018-2032)
North AmericaOutlook (USD Billion, 2018-2032)
North America Poultry Vaccines by Diseases
Infectious Bronchitis
Marek’s Disease
North America Poultry Vaccines by Technology
Toxoid
Recombinant
Inactivated
Live Attenuated Vaccines
North America Poultry Vaccines by Dosage Form
Duct
Liquid
Freeze Dried Vaccines
US Outlook (USD Billion, 2018-2032)
US Poultry Vaccines by Diseases
Infectious Bronchitis
Marek’s Disease
US Poultry Vaccines by Technology
Toxoid
Recombinant
Inactivated
Live Attenuated Vaccines
US Poultry Vaccines by Dosage Form
Duct
Liquid
Freeze Dried Vaccines
CANADA Outlook (USD Billion, 2018-2032)
CANADA Poultry Vaccines by Diseases
Infectious Bronchitis
Marek’s Disease
CANADA Poultry Vaccines by Technology
Toxoid
Recombinant
Inactivated
Live Attenuated Vaccines
CANADA Poultry Vaccines by Dosage Form
Duct
Liquid
Freeze Dried Vaccines
Europe Outlook (USD Billion, 2018-2032)
Europe Poultry Vaccines by Diseases
Infectious Bronchitis
Marek’s Disease
Europe Poultry Vaccines by Technology
Toxoid
Recombinant
Inactivated
Live Attenuated Vaccines
Europe Poultry Vaccines by Dosage Form
Duct
Liquid
Freeze Dried Vaccines
Germany Outlook (USD Billion, 2018-2032)
Germany Poultry Vaccines by Diseases
Infectious Bronchitis
Marek’s Disease
Germany Poultry Vaccines Technology
Toxoid
Recombinant
Inactivated
Live Attenuated Vaccines
Germany Poultry Vaccines by Dosage Form
Duct
Liquid
Freeze Dried Vaccines
France Outlook (USD Billion, 2018-2032)
France Poultry Vaccines by Diseases
Infectious Bronchitis
Marek’s Disease
France Poultry Vaccines by Technology
Toxoid
Recombinant
Inactivated
Live Attenuated Vaccines
France Poultry Vaccines by Dosage Form
Duct
Liquid
Freeze Dried Vaccines
UK Outlook (USD Billion, 2018-2032)
UK Poultry Vaccines by Diseases
Infectious Bronchitis
Marek’s Disease
UK Poultry Vaccines by Technology
Toxoid
Recombinant
Inactivated
Live Attenuated Vaccines
UK Poultry Vaccines by Dosage Form
Duct
Liquid
Freeze Dried Vaccines
ITALY Outlook (USD Billion, 2018-2032)
ITALY Poultry Vaccines by Diseases
Infectious Bronchitis
Marek’s Disease
ITALY Poultry Vaccines by Technology
Toxoid
Recombinant
Inactivated
Live Attenuated Vaccines
ITALY Poultry Vaccines by Dosage Form
Duct
Liquid
Freeze Dried Vaccines
SPAIN Outlook (USD Billion, 2018-2032)
Spain Poultry Vaccines by Diseases
Infectious Bronchitis
Marek’s Disease
Spain Poultry Vaccines by Technology
Toxoid
Recombinant
Inactivated
Live Attenuated Vaccines
Spain Poultry Vaccines by Dosage Form
Duct
Liquid
Freeze Dried Vaccines
Rest Of Europe Outlook (USD Billion, 2018-2032)
Rest Of Europe Poultry Vaccines by Diseases
Infectious Bronchitis
Marek’s Disease
REST OF EUROPE Poultry Vaccines by Technology
Toxoid
Recombinant
Inactivated
Live Attenuated Vaccines
REST OF EUROPE Poultry Vaccines by Dosage Form
Duct
Liquid
Freeze Dried Vaccines
Asia-Pacific Outlook (USD Billion, 2018-2032)
Asia-Pacific Poultry Vaccines by Diseases
Infectious Bronchitis
Marek’s Disease
Asia-Pacific Poultry Vaccines by Technology
Toxoid
Recombinant
Inactivated
Live Attenuated Vaccines
Asia-Pacific Poultry Vaccines by Dosage Form
Duct
Liquid
Freeze Dried Vaccines
China Outlook (USD Billion, 2018-2032)
China Poultry Vaccines by Diseases
Infectious Bronchitis
Marek’s Disease
China Poultry Vaccines by Technology
Toxoid
Recombinant
Inactivated
Live Attenuated Vaccines
China Poultry Vaccines by Dosage Form
Duct
Liquid
Freeze Dried Vaccines
Japan Outlook (USD Billion, 2018-2032)
Japan Poultry Vaccines by Diseases
Infectious Bronchitis
Marek’s Disease
Japan Poultry Vaccines by Technology
Toxoid
Recombinant
Inactivated
Live Attenuated Vaccines
Japan Poultry Vaccines by Dosage Form
Duct
Liquid
Freeze Dried Vaccines
India Outlook (USD Billion, 2018-2032)
India Poultry Vaccines by Diseases
Infectious Bronchitis
Marek’s Disease
India Poultry Vaccines by Technology
Toxoid
Recombinant
Inactivated
Live Attenuated Vaccines
India Poultry Vaccines by Dosage Form
Duct
Liquid
Freeze Dried Vaccines
Australia Outlook (USD Billion, 2018-2032)
Australia Poultry Vaccines by Diseases
Infectious Bronchitis
Marek’s Disease
Australia Poultry Vaccines by Technology
Toxoid
Recombinant
Inactivated
Live Attenuated Vaccines
Australia Poultry Vaccines by Dosage Form
Duct
Liquid
Freeze Dried Vaccines
Rest of Asia-Pacific Outlook (USD Billion, 2018-2032)
Rest of Asia-Pacific Poultry Vaccines by Diseases
Infectious Bronchitis
Marek’s Disease
Rest of Asia-Pacific Poultry Vaccines by Technology
Toxoid
Recombinant
Inactivated
Live Attenuated Vaccines
Rest of Asia-Pacific Poultry Vaccines by Dosage Form
Duct
Liquid
Freeze Dried Vaccines
Rest of the World Outlook (USD Billion, 2018-2032)
Rest of the World Poultry Vaccines by Diseases
Infectious Bronchitis
Marek’s Disease
Rest of the World Poultry Vaccines by Technology
Toxoid
Recombinant
Inactivated
Live Attenuated Vaccines
Rest of the World Poultry Vaccines by Dosage Form
Duct
Liquid
Freeze Dried Vaccines
Middle East Outlook (USD Billion, 2018-2032)
Middle East Poultry Vaccines by Diseases
Infectious Bronchitis
Marek’s Disease
Middle East Poultry Vaccines by Technology
Toxoid
Recombinant
Inactivated
Live Attenuated Vaccines
Middle East Poultry Vaccines by Dosage Form
Duct
Liquid
Freeze Dried Vaccines
Africa Outlook (USD Billion, 2018-2032)
Africa Poultry Vaccines by Diseases
Infectious Bronchitis
Marek’s Disease
Africa Poultry Vaccines by Technology
Toxoid
Autoimmune Diseases
Inactivated
Live Attenuated Vaccines
Africa Poultry Vaccines by Dosage Form
Duct
Liquid
Freeze Dried Vaccines
Latin America Outlook (USD Billion, 2018-2032)
Latin America Poultry Vaccines by Diseases
Infectious Bronchitis
Marek’s Disease
Latin America Poultry Vaccines by Technology
Toxoid
Recombinant
Inactivated
Live Attenuated Vaccines
Latin America Poultry Vaccines by Dosage Form
Duct
Liquid
Freeze Dried Vaccines
Research Methodology on Poultry Vaccines Market
1. Introduction
Research methodology refers to the approach of conducting the research study. Its main purpose is to outline the strategies or plans the researcher uses to conduct a research study. This section explains the research design, data collection methods and methodology, data sources, data analysis techniques, and sampling method used for this research study.
2. Research Design
The research design is an outline or framework detailing how the research study is expected to proceed. This research study adopted a descriptive study approach using a combination of secondary and primary research designs. The primary and secondary data sources used for this study include reports from primary research sources such as interviews, focus groups, questionnaires, surveys, and desk research.
3. Data Collection Methods and Methodology
The data collection methods and methodology used in this research study are described in detail below.
3.1 Secondary Data Sources
The secondary data sources used in this research study include reports from secondary sources such as web-based and online databases, industry magazines, journals, and news articles.
3.2 Primary Data Sources
The primary data sources used in this study include interviews, focus groups, questionnaires, and surveys. The primary data sources were used to collect detailed information from different stakeholders in the market. The stakeholders included poultry farmers, veterinarians, and poultry feed specialists. The primary data collected was interpreted and assessed to draw conclusions and validate the secondary data.
4. Data Analysis Techniques
The data analysis techniques used for this study include qualitative and quantitative analyses. The qualitative analysis techniques used for this study include descriptive statistics, theme analysis, content analysis, concept analysis, and content mapping. The quantitative analysis techniques used include ratio analysis, regression, correlation analysis, and ANOVA.
5. Sampling Method
The sampling method used for this study was stratified sampling. Stratified sampling was used to select the population of the research study. The population for this research study included poultry farmers, veterinarians, and poultry feed specialists. The stratified sampling was done based on region, age, and other demographic factors.
6. Conclusion
This research study adopted a descriptive study approach to analyze the Poultry Vaccines Market. The primary and secondary data collection methods and data analysis techniques used in this research study were discussed in detail. The stratified sampling method was used to select the population for this study.